Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HIVDIS

Financiado

Cerrado

Impact of socio economical inequalities in the progression of HIV infection at i...

Impact of socio economical inequalities in the progression of HIV infection at individual and contextual level in Europe "Background. The HIV epidemic is a major public health issue in Europe. Over the last decade significant changes in the epidemic have taken place with a increasing proportion of HIV infections being in migrants and women. In turn,... ver más

29/06/2014

ISCIII

159K€

Presupuesto del proyecto: 159K€

Líder del proyecto

INSTITUTO DE SALUD CARLOS III (ISCIII) No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 23M€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-06-29 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ISCIII

0.00€ | Lider

Proyectos interesantes

SAF2016-77894-R

Medical Technol...

Infectious Dise...

145K€ Cerrado

REACH

Medical Technol...

Public Health

4M€ Cerrado

COBRA

Medical Technol...

Health Informat...

8M€ Cerrado

CENTROS COMUNITARIOS CASA: CENTROS DE CHECKPO...

Medical Technol...

Public Health

25K€ Cerrado

VIH E INTERCULTURALIDAD: PROYECTO DE EDUCACIÓ...

Medical Technol...

Public Health

24K€ Cerrado

CENTROS COMUNITARIOS CASA: CENTROS DE CHECKPO...

Medical Technol...

Public Health

25K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

INSTITUTO DE SALUD CARLOS III (ISCIII) No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 23M€

Presupuesto del proyecto 159K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Background. The HIV epidemic is a major public health issue in Europe. Over the last decade significant changes in the epidemic have taken place with a increasing proportion of HIV infections being in migrants and women. In turn, these groups might not fully benefit from life-saving antiretroviral treatments (ART), because of barriers to HIV testing and to ART. To date no study with sufficient sample size has explored the role of socio-economic determinants in heath of HIV infected patients in Europe. The role of contextual factors in the health of HIV patients, such as ethnic density, and lower area income level, have not been studied. Objective. We aim to study the socio-economic determinants of inequalities in HIV diagnosis, disease progression, and treatment initiation in Western Europe. Moreover, we will explore the extent to which the variability of HIV prognosis is attributable to either individual (gender, ethnicity, social class) or contextual factors (income area, ethnic density). We will use the routinely collected data of HIV infected patients that will be merged by the newly established EuroCoord collaboration. Methods. The routinely collected database from the newly established EuroCoord collaboration provides information on socio-economic determinants on 250,000 HIV infected individuals from various EU countries. HIV disease progression will be defined as rate of CD4 decline or time to AIDS or death. Marginal structural models to account for time varying confounding will be used to explore differences by socio-economic groups of the effect of ART on the risk of AIDS and mortality. Multilevel and latent variable models will be used to explore the role of contextual factors on HIV progression. Public health implications. This research will help EU health care planners to identify and target groups of HIV infected individuals likely to face barriers to HIV testing and ART and thus prevent HIV-related mortality in more vulnerable populations."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores